ResMed stock is experiencing conflicting movements, with some reports indicating it is trading up, while others suggest it is falling or has hit a 52-week low. The stock's movement may be related to post-earnings scrutiny and shifting investor confidence. The outlook for ResMed stock is uncertain, with some predictions of a potential spike and others noting downgraded shares and trimmed price targets.